BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05082025-completion@plaintrial.com
DTSTAMP:20260928T070654Z
DTSTART;VALUE=DATE:20251212
SUMMARY:Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulv
 estrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA\, PIK3R1) and
 /or PTEN Alterations — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05082025
URL:https://plaintrial.com/trial/NCT05082025
END:VEVENT
END:VCALENDAR